148 Insulin dependent diabetes results in worse outcomes compared to non-insulin dependent diabetes following coronary artery bypass graft surgery (CABG). (16th May 2012)

• Record Type: Journal Article
• Authors: Rathod, K S; Gallagher, S M; Hassan, S; Lovell, M J; Jones, D A; Rathod, V S; Bromage, D; Uppal, R; Knight, C; Mathur, A; Wragg, A; Kapur, A
• Is Part Of: Heart. Volume 98(2012)Supplement 1
• Page Start: A82
• Page End: A82
• Publication Date: 2012-05-16
• Subjects: Insulin dependent diabetes mellitus -- non-insulin dependent diabetes mellitus -- elective CABG; Heart -- Diseases -- Treatment -- Periodicals; Cardiology -- Periodicals; 616.12
• DOI: 10.1136/heartjnl-2012-301877b.148
• Languages: English
• ISSNs: 1355-6037

Abstract

Abstract : Aims: Previous research has demonstrated that patients with diabetes mellitus (DM) have a worse prognosis than patients without diabetes following coronary artery bypass graft surgery (CABG). However, patients with insulin treated diabetes (ITD) may have a different prognosis when compared with non-insulin treated diabetic patients (NITD) after CABG. There is limited data investigating long term outcomes following CABG in patients with ITD and NITD patients. This study compared outcomes at 5 years following CABG in these two patient groups. Methods: 7442 consecutive patients underwent CABG at a single cardiac centre between 2003 and 2011. We identified 2471 patients with DM within this group. Demographic and procedural data were collected at the time of intervention. All cause mortality data were obtained from the Office of National Statistics via the BCIS/CCAD national audit out to a median of 2.80 years (CI 2.08 to 3.56 years). Results: Of 2471 patients with DM, 741 (30.0%) were ITD and 1730 (70.0%) were NITD. ITD patients had significantly higher rates of previous MI (65% vs 52%, p<0.0001) and higher rates of renal disease (10% vs 3%, p<0.0001). There were more female patients in the ITD group compared to the NITD patients (26% vs 20%, p=0.001). There was no difference in Age, rates of Hypertension, Hypercholestrolaemia, Previous PCI, or In-Hospital MACE between the two groups. At 5 years, there was no difference between non-diabetic patients and the NITD (p=0.63). However, by 5 years all cause mortality was greater in the ITD group than in the NITD group 14% vs 9% (p<0.001). After adjusting for comorbidities, using multivariate analysis, ITD remained an independent predictor of long-term mortality (HR 1.64, 95% CI 1.19 to 2.25, p<0.002). Conclusions: Our data suggest that insulin treatment is an independent predictor of long term mortality for patients undergoing CABG. Treatment with insulin rather than diabetic status alone is an important factor affecting outcome in patients with coronary artery disease requiring surgical intervention. Furthermore, these differences in mortality appear after the first year. Hence there is a role for intensive medical therapy in ITD patients and further research is required to confirm these outcomes.